Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-28

FDA Approved: DEFERASIROX ORAL GRANULES — Supplemental Application (EPIC PHARMA, LLC)

View source ↗

Summary

The FDA approved a supplemental application to authorize Deferasirox Oral Granules (DEFERASIROX) from Epic Pharma, LLC, for the treatment of iron overload, expa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox Oral Granules (DEFERASIROX)

Snippet

SUPPL AP for DEFERASIROX ORAL GRANULES (DEFERASIROX)